Live Breaking News & Updates on Orphagen Pharmaceuticals|Page 1

Stay updated with breaking news from Orphagen pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Orphagen's ACC therapy receives FDA rare pediatric disease

Orphagen has received a rare pediatric disease designation for OR-449 from the US Food and Drug Administration (FDA) to treat paediatric ACC. ....

Scott Thacher , Orphagen Pharmaceuticals , Drug Administration , Investigational New Drug ,

Orphagen Pharmaceuticals Presents Data on Downstream Targets of SF-1 Antagonist OR-449 at ENDO 2022

Orphagen Pharmaceuticals Presents Data on Downstream Targets of SF-1 Antagonist OR-449 at ENDO 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San Antonio , United States , Jessica Yingling , Peter Houghton , Haiyan Tao , Gray Fox , Pauld Crowe , Scott Thacher , Richardj Auchus , Neil Raheja , Paul Crowe , Ut Health Sciences Center , Little Dog Communications Inc , Company Contact , Orphagen Pharmaceuticals , Meeting Of The Endocrine Society , Annual Meeting , Endocrine Society , Vice President , Drug Discovery , Health Sciences Center , Downstream Targets ,